FORM 13G HOLDINGS REPORT

Company

FENNEC PHARMACEUTICALS INC.

Filed

February 14, 2005

Accession Number

0001172661-05-000095

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →